![](https://monteverdelaw.com/wp-content/uploads/case-logo/immune-design-corp.jpg)
We are investigating the Board of Directors of Immune Design Corp. (NasdaqGS: IMDZ) regarding its sale to Merck Sharp & Dohme Corp. for $5.85 per each share of Immune Design Corp.
We are investigating the Board of Directors of Immune Design Corp. (NasdaqGS: IMDZ) regarding its sale to Merck Sharp & Dohme Corp. for $5.85 per each share of Immune Design Corp.